Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IMMUNOMEDICS INC (IMMU)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 28.4% | 15.6% | 35.9% | 4.7% | 16.9% | 7.9% | 1.3% |
| Gross profit | 100.0% | 71.6% | 84.4% | 64.1% | 95.3% | 83.1% | 92.1% | 98.7% |
| Sales and marketing | 8969.2% | 316.4% | 28.2% | 31.8% | 13.6% | 12.5% | 16.7% | 2.6% |
| Research and development | 86396.9% | 4605.0% | 1674.9% | 1654.5% | 738.3% | 372.5% | 572.0% | 74.1% |
| General and administrative | 14848.5% | 1692.3% | 941.7% | 203.0% | 161.0% | 91.6% | 124.0% | 17.6% |
| EBITDA | -108819.0% | -6174.0% | -2530.6% | -1802.2% | -807.4% | -387.2% | -596.9% | 9.0% |
| Depreciation | 1295.6% | 60.2% | 29.9% | 22.8% | 10.2% | 6.3% | 20.9% | 4.6% |
| EBIT | -110114.6% | -6234.2% | -2560.4% | -1825.0% | -817.6% | -393.5% | -617.8% | 4.4% |
| Pre-tax income | -121125.1% | -12696.2% | -4957.4% | -1985.3% | -850.3% | -392.9% | -230.6% | 4.5% |
| Income taxes | 0.0% | 7.2% | 0.7% | -156.3% | 1.0% | 0.1% | 0.9% | 0.6% |
| Net income | -121081.4% | -12701.2% | -4956.1% | -1825.9% | -849.1% | -391.8% | -229.4% | 4.2% |
|